DFE Pharma is headquartered in Goch, Germany. Their roots date back to more than 100 years ago, when two dairy producers, in both the Netherlands and New Zealand joined to become the world’s leading excipient manufacturer. The abbreviation of these two companies DMV-Fonterra Excipients, led to the first part of name, “DFE”, which is complemented by “Pharma”. The company is focused on pharmaceutical and nutraceutical industry, by providing a broad premium quality portfolio of excipients for various applications.

Since 2020, DFE Pharma is jointly owned by Royal FrieslandCampina, one of the world’s top multi-national dairy companies, and CVC Capital Partners, a leading global investor, holding a 50% share each of them. The combination of these two shareholders supports DFE Pharma's growth ambitions and provides further opportunities to excel as a global leader in pharmaceutical ingredients. They are serving over 5,000 customers in 100+ countries worldwide.

They are committed to improve patients’ lives, driven by our purpose your medicines, our solutions. Moving to a healthier world.

For more information, please visit website